|
FAM55C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.562180E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.903430E-03 |
| Normal-vs-Stage2 |
9.381500E-03 |
| Normal-vs-Stage3 |
6.798700E-03 |
| Normal-vs-Stage4 |
1.822020E-01 |
| Stage1-vs-Stage2 |
5.938400E-01 |
| Stage1-vs-Stage3 |
8.584800E-01 |
| Stage1-vs-Stage4 |
4.655600E-01 |
| Stage2-vs-Stage3 |
7.699200E-01 |
| Stage2-vs-Stage4 |
3.564600E-01 |
| Stage3-vs-Stage4 |
4.470800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.036600E-03 |
| Normal-vs-AfricanAmerican |
1.282130E-02 |
| Normal-vs-Asian |
4.690800E-01 |
| Caucasian-vs-AfricanAmerican |
6.379200E-01 |
| Caucasian-vs-Asian |
7.383000E-01 |
| AfricanAmerican-vs-Asian |
6.111400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.297340E-03 |
| Normal-vs-Female |
1.211540E-02 |
| Male-vs-Female |
3.619800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.760000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.099800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.880500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.020900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.905000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.667000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.501800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.439200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.385540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.316210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.766200E-01 |
| Normal-vs-Grade 2 |
1.021990E-02 |
| Normal-vs-Grade 3 |
5.88009999999972E-05 |
| Normal-vs-Grade 4 |
8.486800E-01 |
| Grade 1-vs-Grade 2 |
1.214620E-01 |
| Grade 1-vs-Grade 3 |
1.188190E-02 |
| Grade 1-vs-Grade 4 |
8.982600E-01 |
| Grade 2-vs-Grade 3 |
3.751700E-02 |
| Grade 2-vs-Grade 4 |
1.197630E-01 |
| Grade 3-vs-Grade 4 |
1.103580E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.432800E-04 |
| Normal-vs-ccB subtype |
2.298200E-02 |
| ccA subtype-vs-ccB subtype |
5.614200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.861500E-03 |
| Normal-vs-N1 |
5.170200E-01 |
| N0-vs-N1 |
2.323800E-01 |
|
|
